Moneycontrol PRO

business

Maintain base business revenue guidance of 15% in FY17: Suven

The Contract Research and Manufacturing Services (CRAMS) side of the business has contributed to the June quarter bottomline on the back of good product mix, says Venkat Jasti, CEO, Suven Life Sciences.

first published: Aug 11, 2016 11:49 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347